Design and rationale for the DIVERSITY study: An open‐label, randomized study of dabigatran etexilate for pediatric venous thromboembolism
暂无分享,去创建一个
L. Brandão | M. Brueckmann | M. Luciani | E. Chalmers | L. Mitchell | M. Albisetti | S. Gropper | L. Bomgaars | J. Halton | F. Huang | R. Harper | Bushi Wang | B. Biss | I. Tartakovsky | Ivan Manastirski | Ruth Harper